Nerandomilast in IPF and PPF: A New Option On the Horizon
Featuring: Dr. Shane Shapera There is a new pulmonary fibrosis medication called Nerandomilast that is currently undergoing government approval processes as a treatment for idiopathic pulmonary fibrosis (IPF) and progressive […]